
BABA · NYSE
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $148.40B | $137.30B | $130.35B | $126.49B | $134.57B | $109.48B | $71.98B | $56.15B |
| Cost of Revenue | $89.32B | $82.45B | $81.20B | $80.04B | $85.10B | $64.29B | $39.88B | $30.83B |
| Research & Development | $9.64B | $7.88B | $7.24B | $8.26B | $8.75B | $8.74B | $6.08B | $5.58B |
| Selling, General & Administrative | $4.80B | $6.10B | $5.82B | $6.14B | $5.04B | $8.43B | $3.98B | $3.71B |
| Operating Income | $7.27B | $19.42B | $15.70B | $14.61B | $10.98B | $13.69B | $12.91B | $8.51B |
| Interest Expense | $1.42B | $1.32B | $1.10B | $862.00M | $774.00M | $683.00M | $731.00M | $773.00M |
| Other Income / (Expense) | $220.00M | $467.00M | $853.00M | $848.00M | $1.66B | $1.16B | $1.05B | $32.00M |
| Income Before Taxes | $18.76B | $21.42B | $14.07B | $12.99B | $9.39B | $25.27B | $23.54B | $14.34B |
| Provision for Income Taxes | $4.36B | $4.88B | $3.12B | $2.26B | $4.23B | $4.47B | $2.90B | $2.47B |
| Net Income | $15.02B | $17.93B | $11.08B | $10.60B | $9.82B | $22.98B | $21.10B | $13.10B |
| Basic EPS | $0.83 | $0.95 | $0.55 | $0.50 | $0.45 | $1.06 | $1.00 | $0.63 |
| Diluted EPS | $0.80 | $0.92 | $0.54 | $0.50 | $0.45 | $1.04 | $0.99 | $0.62 |
| Basic Shares Outstanding | 18.57B | 18.79B | 20.18B | 20.98B | 21.56B | 21.62B | 21.02B | 20.64B |
| Diluted Shares Outstanding | 19.23B | 19.32B | 20.36B | 21.11B | 21.79B | 21.98B | 21.35B | 20.99B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Mar 2027 | $6.31 | $4.59 | $8.87 | 5 | ↑2 ↓2 |
| Mar 2028 | $8.96 | $6.85 | $12.77 | 6 | ↑2 ↓2 |
| Mar 2029 | $12.66 | $9.49 | $15.83 | 2 | ↑0 ↓0 |